Adamas Pharmaceuticals

-$0.06 (-1.17%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ADMS and other stocks, options, and ETFs commission-free!

About ADMS

Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric.

CEO
Neil F. McFarlane
Employees
138
Headquarters
Emeryville, California
Founded
2000

ADMS Key Statistics

Market Cap
231.13M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
449.78K
High Today
$5.32
Low Today
$5.09
Open Price
$5.15
Volume
226.47K
52 Week High
$9.15
52 Week Low
$2.43

ADMS Earnings

-$0.99
-$0.66
-$0.33
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 5, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure